QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online September 23, 2003

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JEB Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plowe, C. V. Search for Related Content PubMed PubMed Citation Articles by Plowe, C. V. Social Bookmarking                         What's this?

The Journal of Experimental Biology 206, 3745-3752 (2003)
doi: 10.1242/jeb.00658

Review Article

Monitoring antimalarial drug resistance: making the most of the tools at hand

Christopher V. Plowe

Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA

(e-mail: cplowe{at}medicine.umaryland.edu)

Accepted 26 June 2003

Most countries in resource-poor, malaria-endemic areas lack current and comprehensive information on antimalarial drug efficacy, resulting in sub-optimal antimalarial treatment policies. Many African countries continue to use chloroquine despite very high rates of resistance, and others have changed policies based on limited data, with mixed success. Methods for measuring antimalarial drug efficacy and resistance include in vivo studies of clinical efficacy and parasitological resistance, in vitro susceptibility assays and molecular markers for resistance to some drugs. These methods have the potential to be used in an integrated fashion to provide timely information that is useful to policy makers, and the combined use of in vivo and molecular surveys could greatly extend the coverage of resistance monitoring. Malawi, the first African country to change from chloroquine to sulfadoxine/pyrimethamine at the national level, serves as a case study for resistance monitoring and evidence-based antimalarial policies. Molecular, in vitro and in vivo studies demonstrate that chloroquine-sensitive parasites reemerged and now predominate in Malawi after it switched from chloroquine to sulfadoxine/pyrimethamine. This raises the intriguing possibility of rotating antimalarial drugs.

Key words: Plasmodium falciparum, drug resistance, PfCRT, dihydrofolate reductase, dihydropteroate synthase, chloroquine, sulfadoxine/pyrimethamine

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JEB:

MALARIA IN EXPERIMENTAL BIOLOGY

Kathryn Phillips
JEB 2003 206: 3723-3726. [Full Text]  

This article has been cited by other articles:

				G. Q. Zhang, Y. Y. Guan, H. H. Sheng, B. Zheng, S. Wu, H. S. Xiao, and L. H. Tang Multiplex PCR and Oligonucleotide Microarray for Detection of Single-Nucleotide Polymorphisms Associated with Plasmodium falciparum Drug Resistance J. Clin. Microbiol., July 1, 2008; 46(7): 2167 - 2174. [Abstract] [Full Text] [PDF]

				M. K. Laufer, A. A. Djimde, and C. V. Plowe Monitoring and Deterring Drug-Resistant Malaria in the Era of Combination Therapy Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 160 - 169. [Abstract] [Full Text] [PDF]

				J. D. Johnson, R. A. Dennull, L. Gerena, M. Lopez-Sanchez, N. E. Roncal, and N. C. Waters Assessment and Continued Validation of the Malaria SYBR Green I-Based Fluorescence Assay for Use in Malaria Drug Screening Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1926 - 1933. [Abstract] [Full Text] [PDF]

				Z. Zhou, A. C. Poe, J. Limor, K. K. Grady, I. Goldman, A. M. McCollum, A. A. Escalante, J. W. Barnwell, and V. Udhayakumar Pyrosequencing, a High-Throughput Method for Detecting Single Nucleotide Polymorphisms in the Dihydrofolate Reductase and Dihydropteroate Synthetase Genes of Plasmodium falciparum J. Clin. Microbiol., November 1, 2006; 44(11): 3900 - 3910. [Abstract] [Full Text] [PDF]

				M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740. [Abstract] [Full Text] [PDF]

				M. ALIFRANGIS, S. ENOSSE, R. PEARCE, C. DRAKELEY, C. ROPER, I. F. KHALIL, W. M. NKYA, A. M. RONN, T. G. THEANDER, and I. C. BYGBJERG A SIMPLE, HIGH-THROUGHPUT METHOD TO DETECT PLASMODIUM FALCIPARUM SINGLE NUCLEOTIDE POLYMORPHISMS IN THE DIHYDROFOLATE REDUCTASE, DIHYDROPTEROATE SYNTHASE, AND P. FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENES USING POLYMERASE CHAIN REACTION- AND ENZYME-LINKED IMMUNOSORBENT ASSAY-BASED TECHNOLOGY Am J Trop Med Hyg, February 1, 2005; 72(2): 155 - 162. [Abstract] [Full Text] [PDF]

				K. Stepniewska, W. R.J. Taylor, M. Mayxay, R. Price, F. Smithuis, J.-P. Guthmann, K. Barnes, H. Y. Myint, M. Adjuik, P. Olliaro, et al. In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4271 - 4280. [Abstract] [Full Text] [PDF]

				P. L. Olliaro and W. R. J. Taylor Antimalarial compounds: from bench to bedside J. Exp. Biol., November 1, 2003; 206(21): 3753 - 3759. [Abstract] [Full Text] [PDF]